Stockscreener 앱 받기
2.73
0.74%
0.02
시간 외 거래:
2.75
0.02
+0.73%
전일 마감가:
$2.71
열려 있는:
$2.71
하루 거래량:
27,028
Relative Volume:
0.45
시가총액:
$44.94M
수익:
$22.53M
순이익/손실:
$-7.77M
주가수익비율:
-5.7498
EPS:
-0.4748
순현금흐름:
$-740.00K
1주 성능:
-3.19%
1개월 성능:
-24.38%
6개월 성능:
-27.59%
1년 성능:
-43.36%
1일 변동 폭
$2.70
$2.7799
1주일 범위
$2.6601
$2.85
52주 변동 폭
$2.66
$5.92
Sensus Healthcare Inc Stock (SRTS) Company Profile
명칭
Sensus Healthcare Inc
전화
561-922-5808
주소
851 BROKEN SOUND PARKWAY NW, BOCA RATON, FL
Compare SRTS vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SRTS
Sensus Healthcare Inc
|
2.73 | 44.61M | 22.53M | -7.77M | -740.00K | -0.4748 |
ABT
Abbott Laboratories
|
88.50 | 154.45B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
301.14 | 118.05B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.14 | 103.20B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.95 | 69.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.68 | 49.68B | 6.30B | 1.07B | 1.09B | 1.8406 |
Sensus Healthcare Inc Stock (SRTS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-06 | 개시 | Alliance Global Partners | Buy |
| 2025-01-31 | 개시 | Lake Street | Buy |
| 2024-11-15 | 재확인 | Maxim Group | Buy |
| 2021-02-26 | 업그레이드 | Northland Capital | Market Perform → Outperform |
| 2020-12-16 | 다운그레이드 | Northland Capital | Outperform → Market Perform |
| 2020-08-10 | 업그레이드 | Alliance Global Partners | Neutral → Buy |
| 2020-02-14 | 업그레이드 | Alliance Global Partners | Neutral → Buy |
| 2019-11-07 | 다운그레이드 | B. Riley FBR | Buy → Neutral |
| 2019-01-29 | 다운그레이드 | Northland Capital | Market Perform → Under Perform |
| 2018-09-26 | 개시 | B. Riley FBR | Buy |
| 2017-11-03 | 재확인 | Maxim Group | Buy |
| 2017-06-06 | 개시 | Maxim Group | Buy |
| 2016-08-08 | 개시 | Northland Capital | Outperform |
모두보기
Sensus Healthcare Inc 주식(SRTS)의 최신 뉴스
Sensus Healthcare (SRTS) Holds Steady Near Support as Sector Rotation UnfoldsGamma Flip Level - newsline.com
Sensus Healthcare Secures New $15 Million Credit Facility - The Globe and Mail
Sensus HealthcareEnters $15 Million Revolving Credit Facility With City National Bank Of FloridaSEC Filing - TradingView
Sensus Healthcare (NASDAQ: SRTS) adds $15M secured credit facility - Stock Titan
Sensus Healthcare, Inc. Files Form 8-K with SEC – Company Details and Filing Information for May 2026 - Minichart
Sensus Healthcare shareholders re-elect directors and approve auditor at annual meeting By Investing.com - Investing.com South Africa
Sensus Healthcare shareholders re-elect directors and approve auditor at annual meeting - Investing.com India
Sensus Healthcare Shareholders Back Board, Pay, and Auditor - TipRanks
Sensus Healthcare (SRTS) 2026 meeting backs directors, pay and 2026 auditor - Stock Titan
Insiders Give Up US$51k As Sensus Healthcare Stock Drops To US$2.85 - simplywall.st
Sensus Healthcare (SRTS) Holds Tight Range After Minor DeclineDark Pool Prints - The Legal Advocate
SRTS Q1 2026 Earnings: EPS Misses Estimates, Stock Declines 2.83%Earnings Stability Report - newsline.com
Sensus Healthcare (SRTS) Moves Higher, Testing Key Resistance LevelsZero Lag EMA - thelegaladvocate.com
SRTS Q1 2026 Earnings: EPS Falls Short of Estimates as Revenue Remains UndisclosedUpward Estimate Revision - newsline.com
Sensus Healthcare (SRTS) Posts Weak Q1 2026 — Misses on Both Top and Bottom LinesCrowd Stock Picks - Newser
Sensus Healthcare (SRTS) Q1 2026 Earnings: Miss Sparks ConcernOne-Time Loss Impact - Newser
SRTS to Host Virtual Meeting on May 21 - GuruFocus
Sensus Healthcare Balances Weak Quarter With Growth Catalysts - TipRanks
How The Sensus Healthcare (SRTS) Story Is Shifting With New Targets And 2026 Reimbursement Changes - Yahoo Finance
Number of shareholders of Sensus Healthcare, Inc. – TRADEGATE:5TX - TradingView
Sensus Healthcare Q1 earnings call highlights - MSN
Sensus outlines full year profitability goal for 2026 as new CPT codes take effect - MSN
TradingKey - TradingKey
Skin cancer cases rising in the U.S., report says (Video) - Social News XYZ
Sensus Healthcare 1Q 2026: Revenue $3.39M, EPS $(0.16) — 10-Q Summary - TradingView
[10-Q] Sensus Healthcare, Inc. Quarterly Earnings Report - Stock Titan
Skin cancer cases rising in the U.S., report says - CBS News
SRTS Director Eric Sachetta Buys 1,500 Shares on May 13, 2026 - Meyka
Tranche Update on Sensus Healthcare, Inc.'s Equity Buyback Plan announced on August 8, 2023. - marketscreener.com
Maxim Group Maintains Sensus Healthcare(SRTS.US) With Buy Rating, Maintains Target Price $6 - Moomoo
Sensus Healthcare director Eric Sachetta buys $5,002 in stock - Investing.com India
Sensus Healthcare director Eric Sachetta buys $5,002 in stock By Investing.com - Investing.com Nigeria
Sensus Healthcare (SRTS) director Eric Sachetta adds 1,500 shares in open-market buy - Stock Titan
Sensus Healthcare, Inc. (SRTS) Falls More Steeply Than Broader Market: What Investors Need to Know - MSN
Sensus Healthcare Reports Transition to New Radiotherapy Reimbursement Model - HarianBasis.co
Q1 2026 Sensus Healthcare Inc Earnings Call Transcript - GuruFocus
Sensus Healthcare Q1 Earnings Call Highlights - Barchart.com
Sensus Healthcare Charts Recovery Path Amid Revenue Drop - TipRanks
SRTS Sensus Healthcare stock craters 26.6% after 34% revenue decline raises investor concerns.Expert Entry Points - newser.com
Lake Street Maintains Sensus Healthcare(SRTS.US) With Buy Rating, Cuts Target Price to $4.5 - Moomoo
Sensus Healthcare Announces Amicable Resolution Of Commercial Dispute With SkinCure Oncology - TradingView
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Sensus Healthcare Announces Amicable Resolution of Commercial Dispute with SkinCure Oncology - Business Wire
Sensus Healthcare Inc (SRTS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Sensus Healthcare Inc 주식 (SRTS) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Sachetta Eric | Director |
Feb 24 '26 |
Buy |
3.81 |
2,000 |
7,620 |
142,113 |
| Sachetta Eric | Director |
Nov 21 '25 |
Buy |
3.93 |
7,000 |
27,510 |
140,113 |
| Sachetta Eric | Director |
Nov 13 '25 |
Buy |
4.50 |
2,500 |
11,250 |
133,113 |
| Sardano Joseph C | CHIEF EXECUTIVE OFFICER |
Nov 18 '25 |
Buy |
4.03 |
25,000 |
100,750 |
1,200,293 |
| Sardano Michael | PRESIDENT AND GENERAL COUNSEL |
Nov 18 '25 |
Buy |
3.80 |
1,000 |
3,800 |
118,839 |
| Sardano Michael | PRESIDENT AND GENERAL COUNSEL |
Nov 11 '25 |
Buy |
4.26 |
1,000 |
4,260 |
117,839 |
| Sardano Michael | PRESIDENT AND GENERAL COUNSEL |
Aug 13 '25 |
Buy |
3.37 |
1,000 |
3,370 |
116,839 |
2.43%
자본화:
|
볼륨(24시간):